| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.02.23 | Gilead Sciences: FDA Approves Trodelvy In Pre-treated HR+/HER2- Metastatic Breast Cancer | 1.768 | AFX News | FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said that the U.S. Food and Drug Administration approved Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with unresectable... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.222 |
| NEL | 2.021 |
| NVIDIA | 1.766 |
| DEUTSCHE BANK | 1.648 |
| BAYER | 1.417 |
| BASF | 1.298 |
| MICROSOFT | 1.282 |
| ALPHABET | 1.268 |
| TUI | 1.231 |
| THYSSENKRUPP | 1.217 |
| TESLA | 1.197 |
| SUPER MICRO COMPUTER | 1.116 |
| BYD | 1.109 |
| RHEINMETALL | 1.070 |
| DELIVERY HERO | 1.060 |
| INTEL | 877 |
| AIXTRON SE | 871 |
| COMMERZBANK | 833 |
| META PLATFORMS | 828 |
| AMAZON | 768 |
| AMS-OSRAM | 723 |
| VARTA | 671 |
| SIEMENS ENERGY | 596 |
| PLUG POWER | 589 |
| RENK GROUP | 589 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
